Overview

Bladder cancer is a type of cancer that begins in the cells of the bladder, a hollow, muscular organ located in the lower abdomen that stores urine. It occurs when abnormal cells in the bladder grow uncontrollably, forming a tumor. Over time, these cancerous cells can invade nearby tissues and, in advanced cases, spread (metastasize) to other parts of the body, such as the lymph nodes, lungs, liver, or bones.

Key

LUT177 Therapy

Key Characteristics of Bladder Cancer

Origin

Most bladder cancers start in the urothelial cells, which line the inside of the bladder. These cells are also found in the kidneys, ureters, and urethra, so cancer can sometimes develop in those areas as well.
Less common types of bladder cancer include squamous cell carcinoma and adenocarcinoma, which arise from different cell types in the bladder.

Types of Bladder Cancer

Non-Muscle-Invasive Bladder Cancer (NMIBC):
The cancer is confined to the inner lining of the bladder and has not spread into the deeper muscle layers. This is the most common type at diagnosis.
Muscle-Invasive Bladder Cancer (MIBC):
The cancer has grown into the deeper muscle layers of the bladder wall and has a higher risk of spreading to other organs.
Metastatic Bladder Cancer
The cancer has spread beyond the bladder to distant organs or lymph nodes.

Risk Factors

Smoking (the most significant risk factor).
Exposure to certain chemicals (e.g., in dyes, rubber, or paint industries).
Chronic bladder inflammation or infections.
Family history of bladder cancer.
Age (most cases occur in people over 55).
Gender (men are more likely to develop bladder cancer than women).

Symptoms

Blood in the urine (hematuria), which is the most common symptom.
Frequent urination or urgency to urinate.
Pain or burning during urination.
Lower back or pelvic pain.
Fatigue, weight loss, or bone pain (in advanced stages).

Diagnosis

Bladder cancer is typically diagnosed through:

  • Urine Tests : To check for blood, cancer cells, or biomarkers.
  • Cystoscopy : A procedure where a thin tube with a camera is inserted into the bladder to examine its lining.
  • Imaging Tests: CT scans, MRIs, or ultrasounds to determine the extent of the cancer.
  • Biopsy: Removal of tissue samples for laboratory analysis to confirm the presence of cancer cells.

Importance of Early Detection

Early detection and treatment of bladder cancer significantly improve outcomes. Non-muscle-invasive bladder cancer is highly treatable, while muscle-invasive and metastatic bladder cancer require more aggressive therapies. If you experience symptoms like blood in the urine or persistent urinary issues, consult a healthcare provider promptly for evaluation.

For more information or to discuss your case, please contact us. We invite you to share your medical records for a comprehensive evaluation and to develop a personalized treatment plan. Act now—your health and well-being are our priority.

Contact-us

Treatement

Treatment Options

1. Chemotherapy

Common Regimens:

  • Gemcitabine + Cisplatin (GC): A widely used first-line combination.
  • MVAC (Methotrexate, Vinblastine, Doxorubicin, Cisplatin): A more aggressive regimen.

Cost: €1,000–€3,000 per cycle. A full course costs approximately €18,000.

2. Immunotherapy

Common Drugs:

  • Pembrolizumab (Keytruda): Approved for advanced bladder cancer.
  • Atezolizumab (Tecentriq): Used for patients with high PD-L1 expression.
  • Nivolumab (Opdivo): Maintenance therapy for recurrent cases.

Cost: €14,000–€17,000 per dose. Annual costs range from €60,000–€120,000.

3. Targeted Therapy

Common Drugs:

  • Erdafitinib (Balversa): Approved for patients with FGFR genetic alterations.
  • Enfortumab Vedotin (Padcev): An antibody-drug conjugate used for advanced cases.

Cost: €18,000–€19,000 per month. Annual costs range from €140,000–€195,000.

4. Radiation Therapy

Purpose:Used palliatively to relieve symptoms such as pain or bleeding caused by tumors.

Types:

  • External Beam Radiation Therapy (EBRT): The most common form.
  • Stereotactic Body Radiotherapy (SBRT): For precise targeting of metastases.

Cost:

  • €17,000–€25,000 for a full course of EBRT.
  • SBRT costs €25,000–€40,000 , depending on the number of sessions.

Cost

Additional Costs to Consider

  • Diagnostic Tests: Imaging (CT, MRI, PET scans) and lab tests can cost €500–€5,000.
  • Follow-Up Care: Regular check-ups, blood tests, and scans may add €3,000–€7,000 annually.
  • Supportive Care: Pain management, nutritional support, and psychological counseling can cost €500–€5,000 , depending on needs.

Summary of Costs

Treatment Option Approximate Cost (€)
Chemotherapy€4,000–€28,000 (full course)
Immunotherapy€57,000–€150,000 (annual)
Targeted Therapy€140,000–€195,000 (annual)
Radiation Therapy€25,000–€40,000 (full course)
Diagnostic Tests€500–€5,000
Follow-Up Care€3,000–€7,000 (annual)
Supportive Care€500–€5,000

Take Control of Your Health

Advanced bladder cancer requires a personalized treatment plan tailored to your specific condition. If you or a loved one is facing this diagnosis, it’s essential to explore all available options and work with a specialized healthcare team.
For more information or to discuss your eligibility for advanced treatments, please contact us. We invite you to share your medical records for a comprehensive evaluation and to develop a personalized treatment plan. Act now—your health and well-being are our priority.